INC Research, a therapeutically focused CRO of Raleigh, N.C., has appointed Christopher L. Gaenzle as its general counsel.
Gaenzle will be part of INC Research’s executive team and will report to CEO James Ogle. As general counsel, Gaenzle will be responsible for the company’s overall global legal strategy, including contract negotiations, regulatory issues, strategic acquisitions, customer projects and intellectual property matters. He will provide global leadership for INC Research’s legal resources, including management of the company’s in-house legal department and outside counsel relationships.
Prior to joining INC Research, Gaenzle was assistant general counsel at Pfizer. His experience also includes serving as a partner at Hunton & Williams.